Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept and Methotrexate Extension in Rheumatoid Arthritis
NCT00252668Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jun 2004
- Modality
- Fc-Fusion Proteins
01
Overview
Phase 4, open-label, single-arm trial of etanercept in rheumatoid arthritis (RA), sponsored by Pfizer. Primary endpoint: Long-term Safety. Started Jun 2004; status: completed.
02
Drugs
etanercept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00252668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00252668.